CBLPath Announces Laboratory Contract with Cigna


RYE BROOK, N.Y. — CBLPath has entered into a laboratory provider agreement with Cigna Health Corporation and its affiliates, effective February 15, 2012. This agreement will benefit CBLPath’s physician clients and patients.

• Physician clients will be recognized as a Cigna preferred provider. This status enables ease for filing claims and billing, allowing clinicians to focus on providing the highest quality care to their patients.
• Patients will realize the benefit of their provider being in-network including lower out-of-pocket costs and ease-of-billing. The focus is on their health.

The contract covers all Cigna managed care products in the United States, Puerto Rico, and the U.S. Virgin Islands.

“We recognize that behind each specimen we receive is a human life,” said David W. Bryant, CBLPath’s Chief Executive Officer. “By entering this agreement with Cigna, we are avoiding the bureaucracy that can result from out-of-network medical claims; offering our clinicians and patients ease-of-access to quality healthcare.”

About CBLPath
CBLPath is a national specialty lab with a unique leadership position in the convergence of anatomic, molecular and digital pathology. Beginning from a clinical perspective, we harness molecular testing and digital pathology on an anatomic pathology foundation. CBLPath is committed to helping our clients deliver better medicine, faster. At our core are pathologists; excited about technology and innovation and its promise of helping patients. Through the Best Practice™ Partnership Program we help our pathologist-clients effectively compete against centralized reference laboratories, grow their Practice and remain independent — Keeping Medicine Local™. We provide our subspecialty physician clients comprehensive diagnostics and timely, accurate reports enabling the best patient care. For more about the company, please visit www.CBLPath.com.